from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2725c/hflX

LFCtreatmentdescriptionclass of inhibitor

0.176

Amikacinug/mL Amikacintranslation

1.844

Cap5-10ug/mL Capreomycintranslation

2.184

Rox10-50 ug/mL Roxithromycintranslation

2.681

SM2-5 ug/mL Streptomycintranslation

0.481

Tet5-10 ug/mL Tetracyclinetranslation

-0.301

Rif0.2-5ug/mL Rifampicintranscription

-0.190

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.337

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.840

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.717

CPZ10-50 ug/mL Chlorpromazinerespiration

0.818

Clofazimine10-13 ug/mL Clofaziminerespiration

0.169

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.069

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.540

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.204

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.346

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.357

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.503

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.211

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.020

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.226

KCN5-20 ug/mL Potassium cyaniderespiration

0.348

NaN30.2-2 mM Sodium aziderespiration

-0.225

Nigericin50 uM Nigericinrespiration

-0.843

TRC10-150 ug/mL Triclosanrespiration

-0.499

TRZ10-25 ug/mL Thioridazinerespiration

0.776

Valinomycin0.5-10 uM Valinomycinrespiration

-0.162

ZnSO42 mM ZnSO4respiration

-0.295

menadione6-10 ug/mL Menadionerespiration

0.420

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.375

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.151

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.438

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.360

NRP_1Non-replicating persistence stage 1dosRassociated

0.288

Amp0.2mg/mL AmpicillincellWall

0.137

Cephalexin20-100 ug/mL CephalexincellWall

0.522

Cerulenin0.32-5 ug/mL CerulenincellWall

0.257

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.242

EMB10-20 ug/mL EthambutolcellWall

0.030

Eta12-40 ug/mL EthionamidecellWall

0.294

INH0.2-0.4 ug/mL IsoniazidcellWall

0.118

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.365

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.560

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.585

BZA0.12 mg/mL BenzamidearomaticAmides

-0.871

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.975

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.526

H2O24 mM hydrogen peroxideDNAdamaging

-0.098

Levo10 ug/mL LevofloxacinDNAdamaging

-0.328

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.271

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.246

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.367

UVUV-irradiationDNAdamaging

-0.064

ARP41-4 ug/mL Antitubercular compound ARP4?

0.253

Antimycin12.5-50 ug/mL Antimycin A?

0.427

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.166

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.091

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.113

PA8240.2-2 ug/mL PA-824?

-0.169

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.259

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.625

Verapamil50 uM Verapamil?

0.282

mercaptoethanol2 mM 2-Mercaptoethanol?

0.923

methoxatin10-20 ug/mL Methoxatin?